Provided by Tiger Fintech (Singapore) Pte. Ltd.

Seres Therapeutics

9.40
+0.09000.97%
Post-market: 9.610.2100+2.23%16:46 EDT
Volume:56.23K
Turnover:528.19K
Market Cap:81.95M
PE:537.05
High:9.70
Open:9.33
Low:9.17
Close:9.31
Loading ...
Aug 03, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Jul 22, 2021

Major Issues Report

8-K - Current report
Jul 01, 2021

Major Issues Report

8-K - Current report
Jun 21, 2021

Major Issues Report

8-K - Current report
May 21, 2021

Major Issues Report

8-K - Current report
May 20, 2021

Major Issues Report

8-K - Current report
May 05, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
May 04, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
May 04, 2021

Major Issues Report

8-K - Current report
Mar 03, 2021

Employee Stock Ownership

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
Mar 02, 2021

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Mar 02, 2021

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 02, 2021

Major Issues Report

8-K - Current report
Feb 16, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 11, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 08, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 05, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 01, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 01, 2021

Major Issues Report

8-K - Current report
Jan 11, 2021

Major Issues Report

8-K - Current report